Enrique joined LifeArc as Investment Principal in March 2019.
Prior to LifeArc, Enrique was corporate development associate at Mereo BioPharma, where he was involved in new product acquisitions of clinical programmes in rare diseases and niche specialty indications. He also worked as a life sciences strategic consultant and held business development positions at Vernalis and CellCentric.
Earlier, he carried out postdoctoral research in stem cell biology at Universities of Cambridge and Chicago. Enrique holds a PhD in Molecular Medicine from Manchester University, and an MBA from Cambridge Judge Business School.